Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/12/2022 | $11.00 → $12.00 | Buy → Hold | Deutsche Bank |
| 7/11/2022 | $11.00 → $12.00 | Outperform → In-line | Evercore ISI |
| 7/7/2022 | $15.00 | Neutral → Buy | BTIG Research |
| 5/27/2022 | $12.00 | Buy | Stifel |
| 4/1/2022 | $15.00 | Outperform | Credit Suisse |
| 3/30/2022 | Neutral | Guggenheim | |
| 2/25/2022 | $18.00 → $16.00 | Buy | Deutsche Bank |
| 2/24/2022 | $24.00 → $14.00 | Overweight | Morgan Stanley |
Major indices closed mixed on Wednesday as investors and traders weighed in on the minutes of the Federal Open Market Committee’s policy meeting in early February. The minutes stated that although the participants agreed there were recent signs of inflationary pressures moderating, it remained well above the Committee’s longer-run goal of 2% and that the labor market remained very tight, contributing to continuing upward pressures on wages and prices. Meanwhile, the following are the five stocks that are drawing investors’ attention: 1. Tesla Inc (NASDAQ:TSLA): Shares of Tesla closed 1.77% higher on Wednesday. Elon Musk said on Wednesday that the company will make California its global engi
1Life Healthcare Inc (NASDAQ:ONEM) shares are ripping higher Wednesday following reports the Federal Trade Commission won't challenge Amazon.com Inc's (NASDAQ:AMZN) takeover bid. The company also released fourth-quarter results late Tuesday. What Happened: According to a Bloomberg report, the FTC doesn't plan to challenge Amazon's $3.49-billion acquisition of 1Life Healthcare, the parent company of One Medical. The FTC will, however, issue a so-called "pre-consummation warning letter" to both companies to inform them that the agency's investigation isn't closed, despite the antitrust review deadline being reached. "The commission will continue to look at possible harms to competition cr
EFFECT - 1Life Healthcare Inc (0001404123) (Filer)
POS AM - 1Life Healthcare Inc (0001404123) (Filer)
POSASR - 1Life Healthcare Inc (0001404123) (Filer)
BOSTON, Jan. 26, 2022 /PRNewswire/ -- Edenbridge Health today announced the appointment of Rushika Fernandopulle, M.D. to its board of directors, effective immediately. Fernandopulle, a practicing physician and the founder and former CEO of Iora Health, has dedicated his career to improving the quality of healthcare delivery for patients. "We are truly honored that Rushika is joining our board," said Stephen Gordon, M.D., founder and CEO of Edenbridge. "As a physician who prioritizes quality, compassionate healthcare, who led a highly successful company through significant growth, Rushika's guidance will be invaluable to us as we pursue our mission to build a new model of care for frail, c
SAN FRANCISCO, Sept. 01, 2021 (GLOBE NEWSWIRE) -- One Medical (NASDAQ:ONEM), a leading national technology-powered primary care organization, today announced the appointment of Mary Ann Tocio to its board of directors. Ms. Tocio is the former President and Chief Operating Officer of Bright Horizons Family Solutions, and joins the board with over 30 years of leadership and operational experience. In addition, Ms. Tocio brings to One Medical extensive health care and medical management expertise, as well as substantial board experience across both private and public companies, including Iora Health. "We are extremely delighted to welcome Mary Ann Tocio to our board of directors," said Amir
SAN FRANCISCO, June 08, 2021 (GLOBE NEWSWIRE) -- One Medical (NASDAQ: ONEM), a leading national technology-powered primary care organization, today announced the appointment of Scott C. Taylor to its board of directors. As the former Executive Vice President, General Counsel and Corporate Secretary of Symantec Corporation (now called NortonLifeLock), Mr. Taylor has deep expertise in corporate compliance and governance as well as acumen in government affairs, public policy, corporate responsibility, and philanthropy and ethics. He is a seasoned executive with decades of experience as a leader in numerous industries across various stages of business growth. "We are so pleased to welcome Sc
2022 Ending Total Membership Count of 836,000, a 14% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 796,000 and At-Risk Membership Count of 40,000Fourth Quarter 2022 Net Revenue of $274.2 Million, a 19% Increase Year-Over-YearFull Year 2022 Net Revenue of $1.046 Billion, a 68% Increase Year-Over-Year2022 Ending Cash and Marketable Securities of $262.4 Million SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (NASDAQ:ONEM) today announced financial results for the fourth quarter and full year ended December 31, 2022. "This past year at One Medical we extended the impact of our human-centered and t
Third Quarter 2022 Ending Total Membership Count of 815,000, a 14% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 775,000 and At-Risk Membership Count of 40,000Third Quarter 2022 Net Revenue of $261.4 Million, a 73% Increase Year-Over-Year SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (NASDAQ:ONEM) today announced financial results for the third quarter ended September 30, 2022. "Through our human-centered and technology-powered model, we continue to perform, innovate, and grow to delight more members with better health, better care, and lower costs, in a better team environment," said Amir Dan Rubin, Chair & CEO of One
Second Quarter 2022 Ending Total Membership Count of 790,000, a 27% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 750,000 and At-Risk Membership Count of 40,000Second Quarter 2022 Net Revenue of $255.8 Million, a 112% Increase Year-Over-Year SAN FRANCISCO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (NASDAQ:ONEM) today announced financial results for the second quarter ended June 30, 2022. "At One Medical during the second quarter we continued to advance our mission to transform healthcare through our human-centered and technology-powered model," said Amir Dan Rubin, Chair & CEO of One Medical. "We believe that at One Medical we ha
Together, Amazon and One Medical will help more people get better care, when and how they need it For a limited time, One Medical membership is available to new U.S. customers for $144 (28% discount) for the first year—the equivalent of only $12 per month Today, Amazon (NASDAQ:AMZN) and 1Life Healthcare, Inc. (NASDAQ:ONEM, "One Medical"))) announced that Amazon completed its acquisition of One Medical. One Medical's seamless in-office and 24/7 virtual care services, on-site labs, and programs for preventive care, chronic care management, common illnesses, and mental health concerns have been delighting people for the past 15 years. Together, Amazon and One Medical look to deliver exceptio
2022 Ending Total Membership Count of 836,000, a 14% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 796,000 and At-Risk Membership Count of 40,000Fourth Quarter 2022 Net Revenue of $274.2 Million, a 19% Increase Year-Over-YearFull Year 2022 Net Revenue of $1.046 Billion, a 68% Increase Year-Over-Year2022 Ending Cash and Marketable Securities of $262.4 Million SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (NASDAQ:ONEM) today announced financial results for the fourth quarter and full year ended December 31, 2022. "This past year at One Medical we extended the impact of our human-centered and t
Third Quarter 2022 Ending Total Membership Count of 815,000, a 14% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 775,000 and At-Risk Membership Count of 40,000Third Quarter 2022 Net Revenue of $261.4 Million, a 73% Increase Year-Over-Year SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (NASDAQ:ONEM) today announced financial results for the third quarter ended September 30, 2022. "Through our human-centered and technology-powered model, we continue to perform, innovate, and grow to delight more members with better health, better care, and lower costs, in a better team environment," said Amir Dan Rubin, Chair & CEO of One
Deutsche Bank downgraded 1Life Healthcare from Buy to Hold and set a new price target of $12.00 from $11.00 previously
Evercore ISI downgraded 1Life Healthcare from Outperform to In-line and set a new price target of $12.00 from $11.00 previously
BTIG Research upgraded 1Life Healthcare from Neutral to Buy and set a new price target of $15.00
4 - 1Life Healthcare Inc (0001404123) (Issuer)
4 - 1Life Healthcare Inc (0001404123) (Issuer)
4 - 1Life Healthcare Inc (0001404123) (Issuer)
SC 13G/A - 1Life Healthcare Inc (0001404123) (Subject)
SC 13G/A - 1Life Healthcare Inc (0001404123) (Subject)
SC 13G/A - 1Life Healthcare Inc (0001404123) (Subject)